Antiemetic use among Pregnant Women in the United States: the Escalating use of Ondansetron

Project Title Antiemetic use among Pregnant Women in the United States: the Escalating use of Ondansetron
Date
Monday, February 20, 2017
Location
Description

This report examines ondansetron use in pregnancy in the context of other antiemetic use among a large insured United States population of women delivering live births.

Corresponding Author

L. G. Taylor, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Bldg 22, Rm 2406, Silver Spring, MD 20903, USA. E-mail: lockwood.taylor@fda.hhs.gov

Authors

Lockwood G. Taylor PhD, MPH; Steven T. Bird PharmD, PhD, MS; Leyla Sahin MD; Melissa S. Tassinari PhD; Patty Greene PharmD; Marsha E. Reichman PhD; Susan E. Andrade ScD; Katherine Haffenreffer BS; Sengwee Toh ScD

Related Assessments